Polymorphism -238 G/A of tumor necrosis factor alpha gene promoter is a genetic risk factor for ischemic cerebrovascular disease. 2007

Pilar Llamas Sillero, and Jaime Fernández de Velasco Casarrubios, and Arantxa García-Raso, and Elena Meseguer Gancedo, and Ana Belen Santos Montero, and José F Tomás Martínez
Department of Hematology, Fundación Jiménez Díaz, Avda Reyes Católicos, 2, Madrid, Spain. pllamas15@hotmail.com

UI MeSH Term Description Entries
D007511 Ischemia A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION. Ischemias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D002561 Cerebrovascular Disorders A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others. Brain Vascular Disorders,Intracranial Vascular Disorders,Vascular Diseases, Intracranial,Cerebrovascular Diseases,Cerebrovascular Insufficiency,Cerebrovascular Occlusion,Brain Vascular Disorder,Cerebrovascular Disease,Cerebrovascular Disorder,Cerebrovascular Insufficiencies,Cerebrovascular Occlusions,Disease, Cerebrovascular,Diseases, Cerebrovascular,Insufficiencies, Cerebrovascular,Insufficiency, Cerebrovascular,Intracranial Vascular Disease,Intracranial Vascular Diseases,Intracranial Vascular Disorder,Occlusion, Cerebrovascular,Occlusions, Cerebrovascular,Vascular Disease, Intracranial,Vascular Disorder, Brain,Vascular Disorder, Intracranial,Vascular Disorders, Brain,Vascular Disorders, Intracranial
D005260 Female Females
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006147 Guanine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Pilar Llamas Sillero, and Jaime Fernández de Velasco Casarrubios, and Arantxa García-Raso, and Elena Meseguer Gancedo, and Ana Belen Santos Montero, and José F Tomás Martínez
May 2001, Cancer letters,
Pilar Llamas Sillero, and Jaime Fernández de Velasco Casarrubios, and Arantxa García-Raso, and Elena Meseguer Gancedo, and Ana Belen Santos Montero, and José F Tomás Martínez
October 2012, Journal of neuroinflammation,
Pilar Llamas Sillero, and Jaime Fernández de Velasco Casarrubios, and Arantxa García-Raso, and Elena Meseguer Gancedo, and Ana Belen Santos Montero, and José F Tomás Martínez
September 2002, Revista medica de Chile,
Pilar Llamas Sillero, and Jaime Fernández de Velasco Casarrubios, and Arantxa García-Raso, and Elena Meseguer Gancedo, and Ana Belen Santos Montero, and José F Tomás Martínez
January 2006, American journal of nephrology,
Pilar Llamas Sillero, and Jaime Fernández de Velasco Casarrubios, and Arantxa García-Raso, and Elena Meseguer Gancedo, and Ana Belen Santos Montero, and José F Tomás Martínez
April 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics,
Pilar Llamas Sillero, and Jaime Fernández de Velasco Casarrubios, and Arantxa García-Raso, and Elena Meseguer Gancedo, and Ana Belen Santos Montero, and José F Tomás Martínez
January 2013, TheScientificWorldJournal,
Pilar Llamas Sillero, and Jaime Fernández de Velasco Casarrubios, and Arantxa García-Raso, and Elena Meseguer Gancedo, and Ana Belen Santos Montero, and José F Tomás Martínez
November 2005, Alcoholism, clinical and experimental research,
Pilar Llamas Sillero, and Jaime Fernández de Velasco Casarrubios, and Arantxa García-Raso, and Elena Meseguer Gancedo, and Ana Belen Santos Montero, and José F Tomás Martínez
March 1998, Journal of medical virology,
Pilar Llamas Sillero, and Jaime Fernández de Velasco Casarrubios, and Arantxa García-Raso, and Elena Meseguer Gancedo, and Ana Belen Santos Montero, and José F Tomás Martínez
December 2013, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
Pilar Llamas Sillero, and Jaime Fernández de Velasco Casarrubios, and Arantxa García-Raso, and Elena Meseguer Gancedo, and Ana Belen Santos Montero, and José F Tomás Martínez
September 1997, Annals of internal medicine,
Copied contents to your clipboard!